T2 Biosystems Valuation
| TTOO Stock | USD 0 0.0006 21.43% |
T2 Biosystems seems to be fairly valued based on Macroaxis valuation methodology. Our model measures the value of T2 Biosystems from examining the entity fundamentals such as shares owned by institutions of 73.51 %, and Return On Asset of -0.9 as well as evaluating its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that T2 Biosystems' price fluctuation is out of control at this time. Calculation of the real value of T2 Biosystems is based on 3 months time horizon. Increasing T2 Biosystems' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since T2 Biosystems is currently traded on the exchange, buyers and sellers on that exchange determine the market value of TTOO Pink Sheet. However, T2 Biosystems' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0022 | Real 0.002112 | Hype 0.002099 | Naive 0.004054 |
The intrinsic value of T2 Biosystems' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence T2 Biosystems' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of T2 Biosystems helps investors to forecast how TTOO pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of T2 Biosystems more accurately as focusing exclusively on T2 Biosystems' fundamentals will not take into account other important factors: About T2 Biosystems Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of T2 Biosystems. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of T2 Biosystems based exclusively on its fundamental and basic technical indicators. By analyzing T2 Biosystems's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of T2 Biosystems's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of T2 Biosystems. We calculate exposure to T2 Biosystems's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of T2 Biosystems's related companies.T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts. T2 Biosystems operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 182 people.
8 Steps to conduct T2 Biosystems' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates T2 Biosystems' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct T2 Biosystems' valuation analysis, follow these 8 steps:- Gather financial information: Obtain T2 Biosystems' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine T2 Biosystems' revenue streams: Identify T2 Biosystems' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research T2 Biosystems' industry and market trends, including the size of the market, growth rate, and competition.
- Establish T2 Biosystems' growth potential: Evaluate T2 Biosystems' management, business model, and growth potential.
- Determine T2 Biosystems' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate T2 Biosystems' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in TTOO Pink Sheet
T2 Biosystems financial ratios help investors to determine whether TTOO Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in TTOO with respect to the benefits of owning T2 Biosystems security.